News & Articles

Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows

Bees are in decline because of intensive farming, pesticide prevalence and climate change – but human welfare depends on them

Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences

Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more

Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis

Find out how to meet tough quality control and assurance regulations with the latest resources, new methods, and exclusive interviews

Explore topics from perfume profiling, salmonella spp. detection, regulatory biopharma compliance, and in situ hybridization

In this series of webinars, discover the latest techniques and technologies helping researchers advance their biopharmaceuticals workflows

Learn how to optimize your biobanking processes for improved biological material quality, security and traceability

Compact design allows placement of stations in laboratory locations where bench space is limited

For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics

From DNA extraction kits to pipettes and imaging systems, find out the latest products to join the exclusive ranks of lab equipment most loved by scientists across the world

In this guest article by RayBiotech Life, learn how to easily obtain IHC positive controls for different pathologies without the need for patient samples

The independent study is being led by Southampton University Health Sciences

Improved sample safety and faster plate access for large-capacity microplate incubation applications

Their findings show that Paleocene mammals had more muscular builds than those from the Cretaceous or present day

License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research

FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis